Buys
Open market- Shares
- Avg price
- Total value
Mitchell Lawrence Jones - Chief Medical Officer at PALISADE BIO, INC.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- PALI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Mitchell Lawrence Jones in PALISADE BIO, INC.
Sells
Open market- Shares
- -53,869
- Avg price
- $2.04
- Total value
- -$110,016
Net
Past year- Shares
- -53,869
- Share %
- -100%
- Total value
- -$110,016
Reported holdings for Mitchell Lawrence Jones in PALISADE BIO, INC.
Form 4 holding
Chief Medical Officer
PALISADE BIO, INC.
- Security class
- Common Stock
- Shares / value
- 94,009
- Estimated value
- $193,047
- Report date
- 07 Jul 2026
- Price
- $2.05
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
PALISADE BIO, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 655,833
- Estimated value
- $0
- Report date
- 06 Jul 2026
- Price
- $4.76
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
PALISADE BIO, INC.
- Security class
- Phantom Units
- Shares / value
- 289,000
- Estimated value
- Report date
- 04 Sep 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
PALISADE BIO, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 29,000
- Estimated value
- Report date
- 11 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mitchell Lawrence Jones in PALISADE BIO, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.